Cocrystal Pharma, Inc. — Director's Dealing 2021

Aug 23, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cocrystal Pharma, Inc. (COCP)
CIK: 0001412486
Period of Report: 2021-08-20

Reporting Person: PFENNIGER RICHARD C JR (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-08-20	Common Stock	P	40000	$1.028	Acquired	40000	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These securities were purchased in multiple transactions ranging from $1.02 to $1.03, inclusive. The reporting person undertakes to provide to Cocrystal Pharma, Inc., any security holder of Cocrystal Pharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the range set forth in the preceding sentence.